MPM Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

MPM Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-22,487	Closed	-$130K	–	10
2016 Q2	$130K	Hold	22,487	–	–	0.04%	12
2016 Q1	$136K	Hold	22,487	–	–	0.04%	12
2015 Q4	$205K	Hold	22,487	–	–	0.04%	12
2015 Q3	$127K	Hold	22,487	–	–	0.02%	14
2015 Q2	$249K	Hold	22,487	–	–	0.04%	13
2015 Q1	$353K	Hold	22,487	–	–	0.08%	14
2014 Q4	$342K	Hold	22,487	–	–	0.08%	14
2014 Q3	$243K	Hold	22,487	–	–	0.08%	12
2014 Q2	$343K	Hold	22,487	–	–	0.12%	12
2014 Q1	$407K	Hold	22,487	–	–	0.17%	11
2013 Q4	$312K	Buy	+22,487	New	+$259K	0.1%	12

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

MPM Asset Management's SGMO Position: Q3 2016 in Review

MPM Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 22,487 shares — an estimated $130K sold.

MPM Asset Management first reported a position in SGMO in Q4 2013 and held it in 11 quarters. The position peaked at $407K in Q1 2014. 125 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

MPM Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
MPM Asset Management sold 22,487 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $130K.
MPM Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 11 quarters.
MPM Asset Management's SANGAMO THERAPEUTICS INC position peaked at $407K in Q1 2014.
125 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on MPM Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.